Clinical Trials Logo
  1. Home
  2. Healthy Participants
  3. NCT03278080
  4. Details
NCT03278080 Clinical Trial

Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #1

Healthy Participants Clinical Trial

Official title:
Development of Assessment Method of Driving Ability Using Driving Simulator in Healthy Volunteers #1: Measurement Setup of Assessment Criteria for Driving Ability

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03278080
Other study ID # DS-204-01
Secondary ID JapicCTI-173714
Status Completed
Phase N/A
First received
Last updated
Start date September 22, 2017
Est. completion date October 25, 2017

Study information
Verified date October 2017
Source Taisho Pharmaceutical Co., Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to set an optimal measurement time for assessing driving ability in a driving simulator in healthy volunteers.

Recruitment information / eligibility
Status Completed
Enrollment 20
Est. completion date October 25, 2017
Est. primary completion date October 25, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 21 Years to 64 Years
Eligibility Inclusion Criteria: - Body mass index (BMI) =18.5 and <25.0 kg/m2 at screening inspection - No visual impairment (enable to correct the vision with eyeglasses or contact lens) - Receive a prior explanation on the study, able to accept its content, and capable to provide voluntary written consent for participation in this study Exclusion Criteria: - History of drug and food allergy - Routinely drink alcohol before bedtime - Inappropriate for enrollment in this study was judged by principal investigator or subinvestigator

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Road-tracking test
Driving with simulator program for SDLP measurement
• Car-following test
Driving with simulator program for DCV measurement
• Harsh-braking test
Driving with simulator program for BRT measurement

Locations
Country Name City State
Japan Taisho Pharmaceutical Co., Ltd selected site Fukuoka

Sponsors (2)
Lead Sponsor Collaborator
Taisho Pharmaceutical Co., Ltd. Nagoya University

Country where clinical trial is conducted

Japan, 

Outcome
Type Measure Description Time frame Safety issue
Primary Standard Deviation of Lateral Position (SDLP) 60 min.
Secondary Distance Coefficient of Variation (DCV) 25 min.
Secondary Brake Reaction Time (BRT) 15 min.
See also
  Status Clinical Trial Phase
Completed NCT05445440 - A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine Phase 1
Completed NCT03712540 - An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants Phase 1
Completed NCT03649165 - A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants Phase 1
Completed NCT05956002 - A Study to Evaluate the Study Medication (Etrasimod) When Mixed With Food in Healthy Participants Phase 1
Completed NCT05539976 - A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants
Withdrawn NCT04558216 - Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants Phase 1
Withdrawn NCT03007771 - Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia Phase 1
Completed NCT06097390 - A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III Phase 1
Completed NCT05546151 - A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent Phase 1
Completed NCT05056246 - Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants Phase 1
Completed NCT04390776 - Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules. Phase 1
Completed NCT05074459 - A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines Phase 1
Enrolling by invitation NCT06089109 - Creating VIP Corps to Reduce Maternal Deaths N/A
Completed NCT05996250 - Tolerance of an Immersive Virtual Reality Task Evaluating the Spatial Memory of Elderly Subjects N/A
Completed NCT05064800 - PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy Participants Phase 1
Completed NCT04471298 - A Study of Qishenyiqi Dripping Pills in Healthy Participants Phase 1
Completed NCT04914936 - A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196 Phase 1
Completed NCT01681186 - A Study of LY2940680 in Healthy Participants Phase 1
Completed NCT02563262 - Human Neutral Body Posture in Weightlessness N/A
Completed NCT02882386 - Amino Acid Kinetics in Blood After Consuming Different Milk Protein Supplements N/A